Compounds > moxifloxacin
Page last updated: 2024-09-04

moxifloxacin and Tuberculosis, Miliary

moxifloxacin has been researched along with Tuberculosis, Miliary in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gracia García-Miguel, MT; Pérez-Jacoiste, MA; Reche-Sainz, JA1
Dannecker, G; Hess, S; Hospach, T; Magdorf, K; Nossal, R; Uhlemann, F1

Other Studies

2 other study(ies) available for moxifloxacin and Tuberculosis, Miliary

ArticleYear
Papillitis and neuroretinitis of tuberculous etiology.
    Archivos de la Sociedad Espanola de Oftalmologia, 2019, Volume: 94, Issue:7

    Topics: Antitubercular Agents; Drug Therapy, Combination; Humans; Male; Middle Aged; Moxifloxacin; Papilledema; Prednisone; Retinitis; Tuberculoma; Tuberculosis, Miliary; Tuberculosis, Ocular

2019
Life-threatening disseminated tuberculosis as a complication of TNF-α blockade in an adolescent.
    European journal of pediatrics, 2011, Volume: 170, Issue:10

    Topics: Acquired Hyperostosis Syndrome; Adalimumab; Adolescent; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antitubercular Agents; Aza Compounds; Drug Therapy, Combination; Dyspnea; Ethambutol; Female; Fluoroquinolones; Humans; Immunocompromised Host; Immunosuppressive Agents; Moxifloxacin; Quinolines; Severity of Illness Index; Shock, Septic; Treatment Outcome; Tuberculosis, Miliary; Tumor Necrosis Factor-alpha

2011